Gene therapy market size, share 2035

The ongoing evolution in the field of genomics and biotechnology, has catalyzed innovations and advancements of gene therapies across a wide spectrum of disorders - Genetic aberration / mutation is well known to cause several systemic and localized (organ system specific) clinical conditions resulting in severe and hard-to-treat inherited disorders. Such diseases are often treated by modifying the abnormal gene / allele responsible for coding a dysfunctional / non-functional protein.

The global gene therapy market, valued at USD 2.4 billion in 2024, is estimated to reach USD 3.4 billion in 2025 and USD 16.5 billion by 2035, representing a CAGR of 17.0% during the forecast period.

There has been a consistent upward trend in the consolidation activity within the gene therapy domain, growing at a CAGR of 22.22%, since 2015. This can be attributed to the rise in demand for gene therapies and increased competition within this domain, which has further prompted the gene therapy companies to diversify their product portfolios.

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/gene-therapi